X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

OPINION & ORDER Plaintiff in this putative securities fraud class action alleges that Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) and its executives (together, “Defendants”) made false or misleading statements about Spectrum’s progress securing accelerated U.S. Food and Drug Administration (“FDA”) approval of a new drug to treat lung cancer. Plaintiff brings claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. §§78j(b), 78t(a) (the “Exchange Act”), and related regulations. See generally Consolidated Class Action Complaint (the “CCAC”), Dkt. 67.1 On July 25, 2023, Defendants moved to dismiss the action for failure to state a claim pursuant to Federal Rule of Civil Procedure 12(b)(6). See Defs. Not. of Mot., Dkt. 69. For the following reasons, Defendants’ motion is DENIED in part and GRANTED in part. BACKGROUND2 Spectrum is a publicly traded biopharmaceutical company that develops drugs to treat cancer. CCAC 46. Thomas Riga (“Riga”) is Spectrum’s Chief Executive Officer (“CEO”). Id.

1, 47. Francois Lebel (“Lebel”) formerly was Spectrum’s Executive Vice President (“EVP”) and Chief Medical Officer (“CMO”). Id.

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

More From ALM

With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
View Now
Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
View Now
Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
View Now
September 05, 2024
New York, NY

The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.


Learn More
April 29, 2024 - May 01, 2024
Aurora, CO

The premier educational and networking event for employee benefits brokers and agents.


Learn More
May 15, 2024
Philadelphia, PA

The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.


Learn More

Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...


Apply Now ›

Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...


Apply Now ›

Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...


Apply Now ›
04/15/2024
Connecticut Law Tribune

MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS


View Announcement ›
04/11/2024
New Jersey Law Journal

Professional Announcement


View Announcement ›
04/08/2024
Daily Report

Daily Report 1/2 Page Professional Announcement 60 Days


View Announcement ›